Obesity itself does not influence XXXX serum levels in adults.

@entity1 @entity650 @entity712 @entity101 @entity6 @entity28 @entity1674 @entity412 @entity2252 @entity209 @entity413 @entity165
OBJECTIVE: In European countries more than 50% of the population are overweight, 30% with @entity28 . In Poland overweight was present in 41% of @entity1 and 28.7% of @entity1 ( @entity28 15.7% and 19.9%). It was examined whether @entity28 affects serum levels of @entity2252 ( @entity2252 ) and @entity650 ( @entity650 ), which may lead to the consequences of @entity28 , such as type 2 @entity6 , @entity101 , and finally the @entity209 . We aimed to examine whether @entity28 affects the serum levels of @entity2252 and @entity650 . @entity1 AND METHODS: The study involved 144 @entity1 aged 45 to 86 years, 80 subjects with diagnosed @entity28 and 64 with normal body weight,  <= 65 years old (n = 45) and > 65 years old (n = 99). All @entity1 underwent tests of @entity413 , total @entity165 , HDL, LDL, @entity1674 levels, using routine laboratory methods. A test of the concentration of @entity650 and @entity2252 was carried out. The declared level of physical activity (gymnastics, cycling or walking) was considered. RESULTS: It was shown that in @entity1  <= 65 years old, @entity28 was associated with higher levels of @entity650 . When the test group, divided into the above categories, was analyzed for the diagnosis of @entity101 , @entity712 or @entity6 , no statistically significant differences in the investigated parameters were detected. The concentration of @entity2252 did not differ in the investigated subjects, regardless of sex, age, @entity28 , or the declared physical activity. CONCLUSIONS: The concentration of @entity650 in younger @entity1 , including those with normal body weight, correlated with total @entity165 and @entity412 levels, and it was significantly higher in @entity28 @entity1 compared to those with normal body weight.
